CLINICAL_TRIALS
trial_result
· 2019-09-11
Clinical Trial Update: Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML [Phase 3]
Summary
Phase 3 trial comparing nonmyeloablative host conditioning with TLI & ATG to standard of care in acute myeloid leukemia; study terminated with results posted in…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Leukemia, Myeloid, Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2019-09-11